Published: March 9, 2023
Last updated: September 26, 2026
Next review: September 2027, or sooner if major heart failure guidance changes
Written and source -checked by: Adel Galal, Founder and Lead Writer at NextFitLife
Medical review status: This article has been checked against current 2026 ESC, ACC, AHA, Mayo Clinic, and international heart failure guidance. It has not been medically reviewed by a cardiologist.
Diastolic heart failure is heart failure in which the heart may still squeeze reasonably well but has trouble relaxing and filling without pressure rising inside the heart.
Today, clinicians usually discuss this problem within the broader condition called heart failure with preserved ejection fraction, or HFpEF.
That newer term matters. HFpEF is more complicated than simply having a stiff heart, and a normal looking ejection fraction does not mean the heart is functioning normally.
The treatment story has changed too.
Older descriptions focused mainly on diuretics, blood pressure medicines, and lifestyle changes. Current 2026 guidance includes SGLT2 inhibitors, mineralocorticoid receptor antagonists, modern obesity treatment in selected patients, structured exercise, and close treatment of kidney disease, diabetes, atrial fibrillation, sleep apnea, and other conditions that drive HFpEF.
Get Emergency Help for Severe Symptoms
Seek emergency medical care for severe or rapidly worsening shortness of breath, chest pain or pressure, fainting, collapse, severe confusion, blue or gray skin, or coughing white or pink frothy fluid while struggling to breathe.
Do not wait for a routine appointment if breathing becomes severely impaired or symptoms suggest a heart attack, dangerous rhythm problem, or sudden worsening of heart failure.
I am not a dermatologist or A doctor, and this content does not replace professional medical advice. What I share comes from real-life experience, extensive research, and consultation with healthcare providers. Always consult qualified medical professionals for diagnosis and treatment of any health condition.
Quick Answer: What is diastolic heart failure?
Diastolic heart failure usually refers to HFpEF, a heart failure syndrome in which the left ventricle may have preserved squeezing ability but cannot relax or fill normally without higher pressure.
Common symptoms include shortness of breath, reduced exercise ability, fatigue, swelling, trouble breathing while lying flat, cough or wheeze, and fast or irregular heartbeats.
Diagnosis requires more than a preserved ejection fraction. Clinicians use symptoms, examination, natriuretic peptide blood tests, echocardiography, and sometimes exercise or invasive pressure testing.
For a broader overview of heart failure warning signs, read Heart Failure Symptoms and Causes.
Table of Contents
- Diastolic heart failure versus HFpEF
- Preserved ejection fraction does not mean normal
- Symptoms can be easy to miss
- HFpEF has many causes and phenotypes
- Diagnosis needs more than an EF number
- Heart failure treatment changed in 2026
- Obesity and metabolic treatment now matter more
- Exercise and comorbidity care are real treatment
- Know when symptoms are getting worse
- Diastolic dysfunction versus HFpEF
- HFpEF versus HFrEF
- Tests used to confirm HFpEF
- Daily care questions
- References and Sources
- Continue Reading on NextFitLife
- About the Author
- Frequently Asked Questions
Fact 1: Diastolic Heart Failure and HFpEF Are Closely Linked, but Not Identical
The older term diastolic heart failure describes a heart that has trouble relaxing and filling during diastole, the period between contractions.
Modern cardiology more often uses the term HFpEF.
Why the change?
Because HFpEF is not caused by one simple defect.
Abnormal relaxation is important, but patients may also have:
- High filling pressures
- Left atrial enlargement
- Pulmonary hypertension
- Abnormal blood vessel function
- Reduced exercise reserve
- Chronotropic incompetence, meaning the heart rate does not rise normally with activity
- Obesity related inflammation
- Kidney disease
- Atrial fibrillation
- Skeletal muscle and metabolic abnormalities
So HFpEF is now understood as a complex heart and body syndrome.
This also means that diastolic dysfunction seen on an echocardiogram is not automatically the same thing as clinical heart failure.
A person can have impaired relaxation without having the symptoms, congestion, or raised filling pressures needed to diagnose HFpEF.
Key distinction: Diastolic dysfunction is an abnormal heart filling pattern. HFpEF is a clinical heart failure syndrome supported by symptoms plus objective evidence that the heart is operating under abnormal pressure or has related structural or functional disease.
Fact 2: A preserved ejection fraction does not mean the heart is normal
This is the idea that causes the most confusion.
Ejection fraction measures what percentage of the blood inside the left ventricle is pushed out when the heart contracts.
A person can push out a normal percentage while the ventricle remains stiff and fills with too little blood or requires abnormally high pressure to fill.
Imagine a small, stiff container.
It can empty a good percentage of what is inside and still hold less blood than the body needs.
That is one simple way to understand why a preserved EF does not rule out heart failure.
The American Heart Association notes that a normal EF is commonly around 55% to 70%. Older clinical frameworks have commonly used an EF of 50% or more when discussing HFpEF.
The 2026 Second Universal Definition of Heart Failure adds an important update: clinicians should not depend on rigid EF cutoffs alone.
Symptoms, filling pressure, imaging, biomarkers, the cause of disease, and the person's heart failure trajectory all matter.
| Heart Failure Pattern | What Happens? | Ejection Fraction |
|---|---|---|
| HFpEF | The heart often squeezes fairly well, but filling and pressure are abnormal | Traditionally preserved, often 50% or above |
| HFrEF | The left ventricle has reduced squeezing ability | Traditionally 40% or below |
| Improved EF | Previously reduced heart function improves over time | Changes upward after previously reduced function |
The EF value is useful.
It is not the entire diagnosis.
Fact 3: Symptoms Can Be Subtle Before They Become Severe
The most common symptom is often shortness of breath, especially during physical activity.
Early on, a person may simply notice that hills, stairs, shopping, or household work feel harder than before.
Common symptoms include:
- Shortness of breath during activity
- Reduced exercise tolerance
- Fatigue or weakness
- Breathing difficulty while lying flat
- Waking breathless during sleep
- Ankle swelling or leg swelling
- Abdominal fullness or swelling
- Rapid fluid related weight gain
- Cough or wheezing
- Fast or irregular heartbeat
- Dizziness
- Poor appetite or nausea
The symptoms overlap with many other conditions.
Lung disease, anemia, obesity, kidney disease, physical deconditioning, thyroid disorders, sleep apnea, and medicine effects can all cause breathlessness or fatigue.
This is one reason HFpEF can be difficult to diagnose.
What Is Orthopnea?
Orthopnea means breathing becomes harder when you lie flat.
You may begin using extra pillows or sleeping more upright.
What Is Paroxysmal Nocturnal Dyspnea?
This term describes waking from sleep with strong breathlessness and needing to sit or stand to breathe more comfortably.
Both symptoms deserve medical attention, but neither one proves HFpEF by itself.
Fact 4: HFpEF Usually Comes With Other Health Problems
Modern HFpEF care starts by asking what is driving the syndrome.
Common associated conditions include:
- High blood pressure
- Obesity
- Type 2 diabetes
- Atrial fibrillation
- Chronic kidney disease
- Coronary artery disease
- Sleep apnea
- Heart valve disease
- Cardiac amyloidosis
These conditions do more than appear on the same medical chart.
They can shape how HFpEF develops, how symptoms appear, and which treatments make sense.
For example, obesity related HFpEF may need serious attention to weight and metabolic health. A person with atrial fibrillation may need rhythm or rate management. A patient with chronic kidney disease needs treatment that respects kidney function and potassium levels.
That is why one generic “diastolic heart failure medicine list” is no longer enough.
For more on diabetes and cardiovascular risk, read Diabetes and Heart Diseases.
If sleep apnea symptoms are present, see Sleep and Heart Health.
Fact 5: Diagnosing HFpEF Takes More Than an Echocardiogram EF Number
A normal or near normal EF does not confirm HFpEF.
It does not exclude it either.
The clinician usually combines several pieces of evidence.
Medical History and Examination
The clinician may ask about breathlessness, swelling, sleep position, exercise ability, weight changes, palpitations, high blood pressure, diabetes, kidney disease, obesity, sleep apnea, and past heart problems.
BNP or NT proBNP
BNP and NT proBNP are blood markers that can rise when the heart is under abnormal pressure or stretch.
They can support a diagnosis, but they are not perfect.
Obesity can lower natriuretic peptide levels, while atrial fibrillation, kidney disease, and older age can raise them.
A low result therefore needs clinical context, especially when suspicion remains strong.
Echocardiography
An echocardiogram looks at far more than ejection fraction.
It can help assess:
- Heart chamber size
- Wall thickness
- Left atrial enlargement
- Valve disease
- Right heart function
- Estimated pulmonary pressure
- Patterns suggesting abnormal filling pressure
Diagnostic Scores
Specialists may use structured tools such as the H2FPEF score or the HFA PEFF algorithm to estimate how likely HFpEF is.
These combine clinical features, echocardiogram findings, and sometimes natriuretic peptide results.
Exercise Testing
Some people appear fairly normal at rest but develop abnormally high heart filling pressures during exercise.
When the diagnosis remains unclear, exercise echocardiography, cardiopulmonary exercise testing, or invasive pressure measurement can sometimes uncover the problem.
For a broader guide to common medical testing, visit the Medical Tests and Screenings Guide.
Fact 6: HFpEF Medicine Treatment Changed Substantially by 2026
This is where the old article needed the biggest update.
HFpEF was once known for having few treatments that changed clinical outcomes.
That is no longer an accurate summary.
The 2026 European Society of Cardiology heart failure guideline recommends an SGLT2 inhibitor for symptomatic heart failure regardless of ejection fraction.
The same guideline also gives mineralocorticoid receptor antagonists a major role across symptomatic heart failure, including HFpEF.
The current 2026 ACC HFpEF pathway similarly includes SGLT2 inhibitors, MRAs, selected ARNI or ARB therapy, incretin based treatment in suitable patients, and careful management of congestion and associated disease.
| Treatment | Current Role in HFpEF | Main Point |
|---|---|---|
| SGLT2 inhibitor | Foundational treatment in current 2026 guidance | Reduces heart failure events and can improve quality of life in eligible patients |
| MRA | Important current therapy, including steroidal and nonsteroidal options depending on the patient | Requires attention to kidney function and potassium |
| Loop diuretic | Used when congestion or fluid overload is present | Helps relieve swelling and breathlessness but does not represent the entire treatment plan |
| ARNI or ARB | May be used in selected patients | Choice depends on phenotype, blood pressure, kidney function, and other conditions |
| Beta blocker | Often used for another reason such as atrial fibrillation, coronary disease, or blood pressure | It is not automatically the central disease modifying treatment for every HFpEF patient |
This is a major change from the old idea that HFpEF treatment consisted mostly of water pills and blood pressure control.
Do not start, stop, or change any of these medicines because of an article.
SGLT2 inhibitors and MRAs have important precautions involving kidney function, blood pressure, potassium, infections, diabetes status, and other medicines.
Fact 7: Weight and Metabolic Treatment Are Now Part of HFpEF Care
Obesity is not just an unrelated number on the scale in many people with HFpEF.
It can be part of the biology driving the syndrome.
The 2026 ACC HFpEF pathway places much more attention on visceral fat, metabolic dysfunction, and obesity related HFpEF.
The 2026 ESC heart failure guideline also includes modern incretin based treatment for selected patients.
In particular, current ESC guidance says semaglutide or tirzepatide should be considered in selected symptomatic heart failure patients with an EF of at least 45% and obesity to reduce body weight and improve exercise capacity and quality of life.
This is not a recommendation for everyone with HFpEF to use weight loss medication.
These medicines have contraindications, side effects, cost considerations, and monitoring needs. The decision belongs inside a clinician supervised treatment plan.
Why Weight Loss Can Matter
In obesity related HFpEF, sustained weight loss can reduce the physical and metabolic stress placed on the heart and body.
Management may include:
- Nutrition care
- Physical activity when medically stable
- Behavioral support
- Obesity medicines when appropriate
- Bariatric surgery in selected patients
The goal is not crash dieting.
It is better long term heart, kidney, metabolic, and physical function.
Fact 8: Exercise and Treating Other Conditions Are Real HFpEF Therapy
HFpEF is not treated only with tablets.
The 2026 ESC cardiac rehabilitation guideline recommends cardiac rehabilitation for people with HFpEF to improve physical function and health related quality of life.
That is a meaningful update.
Exercise intolerance is one of the most frustrating symptoms of HFpEF, and structured training can help medically stable patients improve what they are able to do.
Exercise still needs to fit the patient.
Someone with stable chronic HFpEF under medical supervision is different from a person with new breathlessness at rest, rapidly increasing swelling, or decompensated heart failure.
Other conditions also need active treatment.
High Blood Pressure
Long term hypertension contributes to heart muscle thickening and stiffness.
Good blood pressure control is a major part of HFpEF care.
For more practical guidance, read How to Lower Blood Pressure Safely.
Atrial Fibrillation
Loss of normal atrial contraction and a rapid or irregular rhythm can make filling problems worse.
Rate control, rhythm management, and stroke prevention may all matter depending on the patient.
Kidney Disease
The heart and kidneys influence each other closely.
Kidney function also affects the safe use of diuretics, MRAs, SGLT2 inhibitors, and other medicines.
Diabetes
Diabetes increases cardiovascular and kidney risk and commonly occurs with HFpEF.
Sleep Apnea
Obstructive sleep apnea is common in people with obesity, hypertension, atrial fibrillation, and HFpEF.
Loud snoring, gasping, witnessed breathing pauses, or major daytime sleepiness deserve assessment.
Coronary Artery Disease
Reduced blood supply to heart muscle can contribute to symptoms and needs its own treatment plan.
Fact 9: HFpEF Can Worsen, So Know Your Normal
A person with stable HFpEF can later develop worsening congestion or decompensated heart failure.
The best early warning signal is often a change from your own normal.
Contact your care team according to your personal action plan if you notice:
- More breathlessness during ordinary activity
- New breathlessness while resting
- Additional difficulty lying flat
- Needing more pillows than before
- Waking breathless during the night
- Increasing ankle or leg swelling
- Increasing abdominal swelling
- Unexpected fluid related weight gain
- New dizziness
- Fast or irregular heartbeats
- A clear fall in walking or exercise ability
- Poor appetite with worsening congestion
If your cardiology team gives you a specific weight threshold or medicine action plan, follow that plan rather than copying someone else's numbers.
Diastolic Dysfunction Is Not Automatically Heart Failure
This distinction deserves its own section because it prevents unnecessary fear.
| Term | What It Means |
|---|---|
| Diastolic dysfunction | The ventricle has abnormal relaxation or filling characteristics. This can exist without clinical heart failure. |
| HFpEF | A heart failure syndrome with symptoms or signs plus objective evidence that supports abnormal cardiac function or filling pressure despite preserved EF. |
| HFrEF | Heart failure in which left ventricular pumping function is reduced. |
If your echocardiogram report says “diastolic dysfunction,” ask the clinician whether you actually meet the criteria for HFpEF.
Those are not interchangeable findings.
What Tests May Be Used When HFpEF Is Unclear?
| Test | What It Helps Show |
|---|---|
| ECG | Heart rhythm, conduction, and clues to previous heart disease |
| BNP or NT proBNP | Evidence of cardiac pressure or stretch, interpreted with age, obesity, kidney function, and rhythm |
| Echocardiogram | EF, chamber size, wall thickness, valve function, filling patterns, and pressure clues |
| Exercise testing | Whether symptoms and abnormal filling become clearer during activity |
| Cardiac MRI | Detailed structure, tissue characteristics, scar, inflammation, or infiltrative disease in selected patients |
| Heart catheterization | Direct measurement of heart and lung circulation pressures when the diagnosis remains uncertain |
No single test replaces the whole clinical picture.
What Should Daily HFpEF Care Focus On?
A good care plan is simple enough to follow but specific enough to catch change early.
- Take prescribed medicines consistently.
- Watch for changes in breathlessness and swelling.
- Track weight if your heart failure team asks you to.
- Manage blood pressure.
- Keep diabetes and kidney care coordinated with heart treatment.
- Address sleep apnea when present.
- Follow an appropriate exercise or cardiac rehabilitation plan when medically stable.
- Work on sustainable weight management when obesity is part of the HFpEF phenotype.
- Know which symptoms require urgent care.
What About Sodium?
Sodium can worsen fluid retention in some people with heart failure.
The right limit should match your clinical plan rather than one universal internet target.
What About Fluid Restriction?
Not every person with HFpEF needs the same fluid restriction.
Your clinician may adjust fluid advice according to congestion, kidney function, sodium level, medicines, and other factors.
What About Potassium?
Do not automatically load the diet with potassium or take potassium supplements because you have heart failure.
MRAs, kidney disease, ARNI or ARB treatment, diuretics, and other medicines can all alter potassium levels.
Even salt substitutes may contain large amounts of potassium.
When Is Diastolic Heart Failure an Emergency?
Seek emergency medical care for:
- Sudden severe shortness of breath
- Severe breathing difficulty while resting
- Chest pain or pressure
- Fainting or collapse
- New severe confusion
- Blue or gray lips or skin with breathing trouble
- Coughing white or pink frothy fluid while severely breathless
- A very fast or irregular heartbeat with chest pain, fainting, or major breathlessness
Do not take extra diuretics, change blood pressure medicines, or alter fluid intake during severe symptoms unless your established emergency plan or treating clinician specifically tells you to do so.
10 Questions to Ask Your Cardiologist
- Do I have diastolic dysfunction, HFpEF, or both?
- What evidence shows that my filling pressure is abnormal?
- What was my ejection fraction?
- What did my BNP or NT proBNP show?
- What is the main cause or phenotype of my HFpEF?
- Should I be taking an SGLT2 inhibitor or MRA?
- Is obesity, diabetes, kidney disease, AFib, or sleep apnea contributing?
- Would cardiac rehabilitation or supervised exercise help me?
- What symptoms or weight changes should make me contact your office?
- Which symptoms mean I should use emergency care instead?
Seven Common Mistakes to Avoid
1. Thinking a Normal EF Means There Is No Heart Failure
HFpEF can occur with a preserved ejection fraction.
2. Assuming Diastolic Dysfunction Automatically Means HFpEF
An abnormal relaxation pattern does not by itself establish the full clinical syndrome.
3. Treating HFpEF as Only a Heart Muscle Problem
Obesity, kidney disease, diabetes, atrial fibrillation, blood pressure, vascular function, sleep apnea, and fitness can all shape the syndrome.
4. Thinking Treatment Is Still Only Diuretics
Modern 2026 therapy includes SGLT2 inhibitors, MRAs, selected additional medicines, metabolic treatment, and structured non drug care.
5. Assuming Beta Blockers or ACE Medicines Are Required for Every HFpEF Patient
These medicines may be useful for specific conditions, but the modern HFpEF treatment plan depends on the patient's phenotype and comorbidities.
6. Copying Someone Else's Sodium, Fluid, or Diuretic Plan
Heart failure care must account for kidney function, blood pressure, potassium, medicines, and congestion.
7. Waiting Until Breathlessness Becomes Severe
Earlier evaluation of declining exercise ability, swelling, or new trouble lying flat can help identify worsening disease sooner.
Conclusion
Diastolic heart failure is better understood today as part of the broader HFpEF syndrome rather than simply a heart that is “too stiff.”
A preserved ejection fraction does not guarantee normal heart function, and diastolic dysfunction on an echocardiogram does not automatically mean someone has clinical HFpEF.
Diagnosis depends on symptoms, examination, biomarkers, imaging, filling pressure, and the conditions that may be driving the syndrome.
Treatment has moved forward quickly. Current 2026 guidance places SGLT2 inhibitors and MRAs at the center of modern HFpEF medical therapy, while obesity treatment, exercise, cardiac rehabilitation, blood pressure care, kidney health, diabetes treatment, atrial fibrillation management, and sleep apnea care can all be important parts of the plan.
Your next step: if you were told you have diastolic dysfunction or diastolic heart failure, ask whether you meet the full criteria for HFpEF, what your filling pressure and natriuretic peptide results show, and which part of the modern treatment plan applies to you.
References and Sources
- European Society of Cardiology.
2026 ESC Guidelines for the Management of Heart Failure. Updated guidance covering SGLT2 inhibitors, MRAs, diuretics, HFpEF, obesity treatment, heart failure staging, and modern medical therapy.Source:
https://www.escardio.org/guidelines/clinical-practice-guidelines/all-esc-practice-guidelines/heart-failure/
- American College of Cardiology.
Management of Heart Failure With Preserved Ejection Fraction: 2026 Expert Consensus Decision Pathway. Covers current HFpEF diagnosis, SGLT2 inhibitors, MRAs, incretin based treatment, ARNI, ARBs, exercise, weight loss, and comorbidity management.Source:
https://www.jacc.org/doi/10.1016/j.jacc.2026.06.018
- American Heart Association, American College of Cardiology, European Society of Cardiology, and World Heart Federation.
Second Universal Definition of Heart Failure, 2026. Covers the updated clinical definition, staging, HF phenotypes, improved EF, objective diagnostic evidence, and classification of causes.Source:
https://pmc.ncbi.nlm.nih.gov/articles/PMC13330914/
- American Heart Association.
Ejection Fraction Heart Failure Measurement. Explains preserved and reduced ejection fraction, why HFpEF can occur with a normal EF, and tests used to measure EF.Source:
https://www.heart.org/en/health-topics/heart-failure/diagnosing-heart-failure/ejection-fraction-heart-failure-measurement
- Mayo Clinic.
Heart Failure With Preserved Ejection Fraction. Current clinical overview covering HFpEF symptoms, causes, risk factors, complications, and the relationship between preserved EF and diastolic heart failure.Source:
https://www.mayoclinic.org/diseases-conditions/heart-failure-with-preserved-ejection-fraction-hfpef/symptoms-causes/syc-20607331
Continue Reading on NextFitLife
- Heart and Cardiovascular Health Guide
for heart disease, blood pressure, cholesterol, heart failure, circulation, warning signs, and cardiovascular prevention - Heart Health 101
for blood pressure, cholesterol, blood sugar, kidney health, food, exercise, sleep, and cardiovascular testing - Heart Failure Symptoms and Causes
for breathlessness, swelling, weight changes, BNP testing, echocardiography, treatment, and emergency warning signs - How to Lower Blood Pressure Safely
for hypertension, home measurement, lifestyle changes, medicines, and questions to discuss with a clinician - Diabetes and Heart Diseases
for blood glucose, cardiovascular risk, kidney health, weight, blood pressure, and coordinated care - Sleep and Heart Health
for sleep apnea, atrial fibrillation, blood pressure, poor sleep, and cardiovascular risk - Exercises for Cholesterol and Heart Health
for aerobic activity, resistance training, heart fitness, and safer exercise planning - Medical Tests and Screenings Guide
for understanding blood tests, heart imaging, screening, and questions to ask before and after medical tests
About the Author
Adel Galal is the founder and lead writer of NextFitLife. His personal interest in health, fitness, nutrition, cardiovascular wellness, and healthy aging spans more than 30 years, and his health and wellness writing experience spans more than 15 years.
Before focusing on NextFitLife, Adel spent 29 years working as an IT Manager for the Nestlé Egypt Region. His professional background includes information systems, data analysis, structured research, planning, problem solving, and information management.
He applies those research skills to consumer health writing by comparing current medical guidance, checking changing treatment recommendations, separating diastolic dysfunction from clinical HFpEF, and translating technical subjects such as filling pressure, ejection fraction, natriuretic peptides, and modern heart failure therapy into plain language.
For this update, Adel reviewed the 2026 ESC Heart Failure Guideline, the 2026 ACC HFpEF Expert Consensus Decision Pathway, the 2026 Second Universal Definition of Heart Failure, current American Heart Association information, and the current Mayo Clinic HFpEF guide.
Adel is not a physician, cardiologist, heart failure specialist, pharmacist, registered nurse, registered dietitian, or other licensed healthcare professional. NextFitLife provides general educational information and does not replace diagnosis, echocardiography, blood testing, prescription treatment, cardiac rehabilitation, or individualized heart failure care.
Learn more about Adel Galal, NextFitLife, sourcing standards, corrections, and the site's editorial approach on the About Us page.
Frequently Asked Questions About Diastolic Heart Failure
What is diastolic heart failure?
Diastolic heart failure commonly refers to HFpEF, a form of heart failure in which the left ventricle may squeeze reasonably well but cannot relax or fill normally without pressure rising.
Is diastolic heart failure the same as HFpEF?
The terms are often used together, but HFpEF is broader. HFpEF can involve abnormal relaxation plus blood vessel, metabolic, kidney, rhythm, pulmonary, and other problems.
Is diastolic dysfunction the same as heart failure?
No. Diastolic dysfunction describes abnormal relaxation or filling. A person needs the broader clinical evidence of heart failure before that finding should be called HFpEF.
Can you have heart failure with a normal ejection fraction?
Yes. A person with HFpEF can have a preserved ejection fraction because the heart can squeeze out a normal percentage while still filling poorly or operating at abnormally high pressure.
What are common diastolic heart failure symptoms?
Symptoms can include shortness of breath, fatigue, reduced exercise ability, ankle swelling, abdominal swelling, trouble breathing while lying down, nighttime breathlessness, cough, dizziness, and fast or irregular heartbeats.
What causes diastolic heart failure?
Common associated conditions include high blood pressure, obesity, diabetes, atrial fibrillation, chronic kidney disease, coronary artery disease, sleep apnea, valve disease, and cardiac amyloidosis.
How is HFpEF diagnosed?
Diagnosis combines symptoms and medical history with examination, BNP or NT proBNP, echocardiography, and sometimes diagnostic scores, exercise testing, cardiac MRI, or invasive pressure measurement.
Can BNP be normal in HFpEF?
Yes. Natriuretic peptide levels can be lower in people with obesity, so a low result does not automatically exclude HFpEF when the clinical suspicion remains high.
What does an echocardiogram show in diastolic heart failure?
An echocardiogram can assess ejection fraction, heart wall thickness, chamber size, valve disease, left atrial size, filling patterns, right heart function, and clues to increased filling or pulmonary pressure.
What medicines are used for HFpEF in 2026?
Current treatment can include SGLT2 inhibitors, mineralocorticoid receptor antagonists, diuretics for congestion, and selected ARNI or ARB treatment. Other medicines depend on blood pressure, atrial fibrillation, kidney disease, coronary disease, diabetes, and the patient's HFpEF phenotype.
Are SGLT2 inhibitors only for people with diabetes?
No. SGLT2 inhibitors are now used for many eligible people with symptomatic heart failure whether or not they have diabetes.
What do diuretics do for diastolic heart failure?
Diuretics help remove excess sodium and water when congestion is present. They can improve swelling and breathlessness but do not represent the entire modern HFpEF treatment plan.
Is finerenone used for HFpEF?
Current evidence supports a role for nonsteroidal mineralocorticoid receptor antagonist treatment such as finerenone in selected HFpEF patients. Kidney function, potassium, other medicines, and individual eligibility need medical review.
Can semaglutide or tirzepatide help obesity related HFpEF?
Current 2026 guidance supports considering these therapies in selected patients with symptomatic HF and obesity because weight loss can improve symptoms, exercise capacity, and quality of life. They are prescription treatments and are not suitable for everyone.
Does exercise help HFpEF?
Yes. The 2026 ESC cardiac rehabilitation guideline recommends cardiac rehabilitation for HFpEF to improve physical function and quality of life in medically stable patients.
Can sleep apnea make HFpEF worse?
Sleep apnea commonly overlaps with obesity, high blood pressure, atrial fibrillation, and HFpEF. Treating diagnosed sleep apnea can be an important part of the wider care plan.
Can diastolic heart failure be cured?
HFpEF is usually managed as a long term syndrome, but symptoms, function, congestion, and risk can improve when the underlying drivers and heart failure itself are treated effectively.
Does HFpEF always get worse?
No single course applies to everyone. The outlook depends on the cause, age, kidney function, other diseases, congestion, treatment response, fitness, and other factors.
When should I contact my heart failure team?
Follow your personal care plan and report meaningful changes such as increasing breathlessness, new difficulty lying flat, worsening swelling, unexpected fluid related weight gain, palpitations, dizziness, or a clear drop in daily activity.
When is diastolic heart failure an emergency?
Seek emergency care for sudden severe breathlessness, chest pain or pressure, fainting, collapse, severe confusion, blue or gray skin, frothy pink or white mucus with breathing difficulty, or a very fast or irregular heartbeat with severe symptoms.
Health & wellness writer with 30+ years of experience in nutrition, fitness, and healthy aging. Founder of NextFitLife.com — evidence-based health guidance.
